CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression. It offers therapeutics that modulate regulatory RNA for genetic diseases with insufficient protein expression. The company is active in markets for central nervous system and metabolic genetic disorders.